Author: Alam et al. Summary: To compare the effects of probiotics supplementation on liver stiffness and steatosis in obese and non-obese patients with NAFLD. The Pragmatic clinical trial included 50 obese (BMI ≥25 kg/m2) and 50 non-obese NAFLD (BMI <25 kg/m2) patients with proper consent procedure. Fibroscan with Controlled Attenuated Parameter (CAP) was done at day 0 and at the end of 6 months. Probiotics supplementation was provided for both groups for 6 months along with other standard management. Current declaration of Helsinki was strictly followed. At inclusion, both groups had comparable characteristics except BMI, metabolic syndrome and WC (cm)